Nucleic Acid Sample Preparation Market to Grow with a CAGR of 6.45% through 2030

Increased Use of Nucleic Acid Testing in Infectious Disease Management and Growing Investments in Genomic Research and Biotechnology are expected to drive the Global Nucleic Acid Sample Preparation Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Nucleic Acid Sample Preparation Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Nucleic Acid Sample Preparation Market stood at USD 2.65 Billion in 2024 and is anticipated to grow with a CAGR of 6.45% in the forecast period, 2026-2030.

As healthcare systems shift toward precision medicine, genetic profiling and nucleic acid analysis have become fundamental for developing patient-specific treatment plans. This transformation is particularly evident in oncology, rare disease diagnostics, and hereditary disorder management. The growing reliance on genetic insights has sharply increased the demand for highly accurate and scalable nucleic acid sample preparation technologies. Major genomic initiatives such as the Human Genome Project, the UK’s 100,000 Genomes Project, and comparable efforts in Asia and the U.S. require consistent, high-throughput extraction and purification of DNA and RNA, further accelerating the need for efficient sample prep systems across research and clinical environments.

The adoption of liquid biopsy technologies is rapidly reshaping clinical diagnostics, particularly in oncology. These minimally invasive methods depend on the reliable isolation of circulating nucleic acids from blood, plasma, and other bodily fluids. As liquid biopsies gain traction for early detection, therapy selection, and disease monitoring, laboratories are increasingly investing in advanced sample preparation platforms capable of handling low-input and cell-free nucleic acid samples with high sensitivity and specificity. This has directly contributed to the expansion of the nucleic acid sample preparation market in both hospital and commercial diagnostic settings.

The global healthcare ecosystem is increasingly favoring decentralized testing solutions, leading to a surge in point-of-care (POC) and at-home diagnostic kits. In response, manufacturers are developing simplified, compact, and automation-compatible nucleic acid preparation modules that can be integrated into portable diagnostic devices. These innovations enable reliable molecular testing outside traditional laboratory settings and open new avenues for market penetration in primary care, rural health, and consumer health diagnostics.

Regulatory agencies such as the U.S. FDA and the European Medicines Agency (EMA) are actively supporting the adoption of molecular diagnostics through streamlined approval pathways and updated compliance standards. This regulatory clarity and endorsement have reduced market entry barriers and prompted pharmaceutical and diagnostic companies to accelerate investment in compliant, high-throughput sample preparation platforms tailored for in vitro diagnostic (IVD) use. As a result, the market is seeing a rise in development of systems that are both scalable and regulatory-ready.

Beyond clinical and pharmaceutical settings, nucleic acid sample preparation is gaining traction in agricultural biotechnology and environmental monitoring. Applications include plant genome analysis, detection of crop pathogens, and microbial ecology studies in soil and water systems. This diversification into non-clinical domains is expanding the customer base and creating new demand for robust sample prep solutions capable of handling diverse and complex sample types, such as plant tissues, soil, and environmental fluids.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Nucleic Acid Sample Preparation Market”

Global Nucleic Acid Sample Preparation Market is segmented into product, Technology, therapeutics area, application, end user, regional distribution, and company.

Based on its application, the Genomics segment has emerged as the predominant market leader, Genomic data is the foundation of precision medicine strategies, especially in oncology, rare diseases, and pharmacogenomics. As healthcare providers and research institutions increasingly rely on genomic profiling to guide therapeutic decisions, the demand for efficient nucleic acid preparation continues to grow. The widespread integration of NGS technologies in both research and clinical settings has elevated the need for robust, scalable, and contamination-free sample preparation systems. NGS workflows require highly purified nucleic acids, free from inhibitors and impurities, which has led to consistent investment in optimized prep solutions.

Large-scale government-funded genomics initiatives such as the All of Us Research Program in the U.S., Genomics England, and other global precision health programs depend on high-throughput, automated sample preparation to process vast volumes of biological material efficiently. Genomics is also essential in tracking viral mutations (e.g., SARS-CoV-2, Influenza) and understanding pathogen-host interactions, which has heightened demand for nucleic acid sample prep tools in public health labs and epidemiological studies.

Based on its end user, Clinical and Diagnostic Laboratories segment dominate the Global Nucleic Acid Sample Preparation Market, primarily due to the increasing volume of molecular diagnostic testing, rising disease burden, and growing reliance on high-throughput, accurate sample preparation in routine clinical workflows. Clinical laboratories routinely perform a wide range of nucleic acid-based diagnostic tests for conditions such as infectious diseases (e.g., COVID-19, tuberculosis, HIV), cancer, and genetic disorders. These tests rely on the consistent extraction and purification of high-quality DNA or RNA from clinical specimens (e.g., blood, saliva, tissue, swabs), making nucleic acid sample preparation a critical upstream step. As molecular diagnostics become increasingly central to patient care, labs are investing in automated sample prep platforms that offer speed, consistency, and minimal hands-on time.

The COVID-19 pandemic significantly expanded the diagnostic testing infrastructure globally, with governments and private labs deploying automated, high-throughput systems for real-time PCR and genomic surveillance. Much of this infrastructure remains in place and is now being repurposed for broader applications including respiratory panels, sexually transmitted infection (STI) testing, and oncology sustaining long-term demand for sample prep reagents and systems.

Based on region, The Asia Pacific region is emerging as the fastest-growing market in the Global Nucleic Acid Sample Preparation Market, fueled by a confluence of economic, healthcare, and technological trends that are accelerating molecular diagnostics, genomic research, and biotechnology development across key countries in the region. Governments across Asia Pacific including China, India, South Korea, Singapore, and Japan are significantly increasing their healthcare budgets and infrastructure, particularly in diagnostics and public health preparedness. The COVID-19 pandemic led to major investments in molecular testing capabilities, many of which have since been institutionalized into national health systems. This has catalyzed demand for nucleic acid sample preparation tools, especially automated and high-throughput platforms that can support routine diagnostics, outbreak surveillance, and genomic sequencing.

The Asia Pacific region is actively investing in large-scale genomics programs such as China’s Precision Medicine Initiative and India’s Genome India project. These initiatives aim to map population-wide genetic variations and promote personalized medicine efforts that require reliable, scalable, and efficient nucleic acid extraction and purification technologies. As next-generation sequencing (NGS), CRISPR gene editing, and pharmacogenomics become increasingly mainstream, the need for standardized sample prep workflows is rising rapidly.

Major companies operating in Global Nucleic Acid Sample Preparation Market are:

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Nucleic Acid Sample Preparation Market is positioned for sustained and robust growth, driven by the expanding adoption of molecular diagnostics, rapid advancements in genomics and biotechnology, and increasing demand for precision medicine across both developed and emerging markets. As automation, regulatory alignment, and high-throughput technologies continue to evolve, market participants that invest in innovation, scalability, and strategic collaborations will be well-placed to capture significant value in this essential and rapidly transforming segment of the life sciences industry.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Consumables, Systems, Accessories & Components), By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others), By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others), By Application (Genomics, Proteomics, Others), By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Nucleic Acid Sample Preparation Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Nucleic Acid Sample Preparation Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]